|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/438 | (2006.01) |
| C07D 471/10 | (2006.01) | ||
| C07D 491/20 | (2006.01) | ||
| A61P 3/10 | (2006.01) |
| (11) | Number of the document | 2621493 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11768163.5 |
| Date of filing the European patent application | 2011-09-20 | |
| (97) | Date of publication of the European application | 2013-08-07 |
| (45) | Date of publication and mention of the grant of the patent | 2016-08-17 |
| (46) | Date of publication of the claims translation | 2016-10-25 |
| (86) | Number | PCT/IB2011/054119 |
| Date | 2011-09-20 |
| (87) | Number | WO 2012/042433 |
| Date | 2012-04-05 |
| (30) | Number | Date | Country code |
| 388102 P | 2010-09-30 | US |
| (72) |
DIDIUK, Mary Theresa, US
DOW, Robert Lee, US
GRIFFITH, David Andrew, US
|
| (73) |
Pfizer Inc. ,
66 Hudson Boulevard East, New York, NY 10001-2192,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | N1-Pirazolo-spiro-ketono acetil-CoA-karboksilazės inhibitoriai |
| N1-PYRAZOLOSPIROKETONE ACETYL-CoA CARBOXYLASE INHIBITORS |
| Payment date | Validity (years) | Amount | |
| 2024-08-09 | 14 | 289.00 EUR |
| 2025-09-20 |